-
1
-
-
30944465690
-
Adenocarcinoma of the esophagus and cardia: A review of the disease and its treatment
-
DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 2006;13:12-30.
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 12-30
-
-
DeMeester, S.R.1
-
2
-
-
33744732468
-
Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and meta-analysis
-
DOI 10.1158/1055-9965.EPI-05-0860
-
Kubo A, Corley DA. Body mass index and adenocarci-nomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomar-kers Prev 2006;15:872-878. (Pubitemid 43823511)
-
(2006)
Cancer Epidemiology Biomarkers and Prevention
, vol.15
, Issue.5
, pp. 872-878
-
-
Kubo, A.1
Corley, D.A.2
-
3
-
-
33846457870
-
Cancer statistics, 2007
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
4
-
-
33745726677
-
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
-
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
-
(2006)
N Engl J Med
, vol.355
, pp. 11-20
-
-
Cunningham, D.1
Allum, W.H.2
Stenning, S.P.3
-
5
-
-
34748814302
-
Induction chemotherapy in Barrett cancer: Influence on surgical risk and outcome
-
discussion 628-631
-
Siewert JR, Lordick F, Ott K, et al. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg 2007;246:624-628; discussion 628-631.
-
(2007)
Ann Surg
, vol.246
, pp. 624-628
-
-
Siewert, J.R.1
Lordick, F.2
Ott, K.3
-
6
-
-
35848968863
-
Final results of a randomized trial comparing preoperative 5-fluorour-acil (F)/cisplatin (P) to surgery alone in adenocarcino-ma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial
-
Boige V, Pignon J, Saint-Aubert B, et al. Final results of a randomized trial comparing preoperative 5-fluorour-acil (F)/cisplatin (P) to surgery alone in adenocarcino-ma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol (Meeting Abstracts) 2007;25:4510.
-
(2007)
J Clin Oncol (Meeting Abstracts)
, vol.25
, pp. 4510
-
-
Boige, V.1
Pignon, J.2
Saint-Aubert, B.3
-
7
-
-
33847156303
-
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis
-
Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226-234.
-
(2007)
Lancet Oncol
, vol.8
, pp. 226-234
-
-
Gebski, V.1
Burmeister, B.2
Smithers, B.M.3
-
8
-
-
40449133028
-
Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: Practical guidelines and current issues
-
Chang F, Deere H, Mahadeva U, et al. Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. Am J Clin Pathol 2008;129:252-262.
-
(2008)
Am J Clin Pathol
, vol.129
, pp. 252-262
-
-
Chang, F.1
Deere, H.2
Mahadeva, U.3
-
9
-
-
0141515468
-
Tumor response to induction chemoradiation: Influence on survival after esophagectomy
-
discussion 636-637
-
Donington JS, Miller DL, Allen MS, et al. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg 2003;24:631-636; discussion 636-637.
-
(2003)
Eur J Cardiothorac Surg
, vol.24
, pp. 631-636
-
-
Donington, J.S.1
Miller, D.L.2
Allen, M.S.3
-
10
-
-
27144456518
-
Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma
-
Langer R, Specht K, Becker K, et al. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res 2005;11:7462-7469.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 7462-7469
-
-
Langer, R.1
Specht, K.2
Becker, K.3
-
11
-
-
33751422222
-
The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer staging system
-
Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006;132:1374-1381.
-
(2006)
J Thorac Cardiovasc Surg
, vol.132
, pp. 1374-1381
-
-
Rizk, N.1
Venkatraman, E.2
Park, B.3
-
12
-
-
0141675069
-
Histomor-phology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
-
Becker K, Mueller JD, Schulmacher C, et al. Histomor-phology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003; 98:1521-1530.
-
(2003)
Cancer
, vol.98
, pp. 1521-1530
-
-
Becker, K.1
Mueller, J.D.2
Schulmacher, C.3
-
13
-
-
0031784518
-
Classification of adenocarcinoma of the oesophagogastric junction
-
Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85:1457-1459.
-
(1998)
Br J Surg
, vol.85
, pp. 1457-1459
-
-
Siewert, J.R.1
Stein, H.J.2
-
14
-
-
34548185461
-
PET to assess early metabolic response and to guide treatment of adeno-carcinoma of the oesophagogastric junction: The MU-NICON phase II trial
-
Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adeno-carcinoma of the oesophagogastric junction: the MU-NICON phase II trial. Lancet Oncol 2007;8:797-805.
-
(2007)
Lancet Oncol
, vol.8
, pp. 797-805
-
-
Lordick, F.1
Ott, K.2
Krause, B.J.3
-
15
-
-
47049120242
-
Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I) A comparison of two phase II trials with long-term follow-up
-
Bader FG, Lordick F, Fink U, et al. Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up. Onkologie 2008; 31:366-372.
-
(2008)
Onkologie
, vol.31
, pp. 366-372
-
-
Bader, F.G.1
Lordick, F.2
Fink, U.3
-
16
-
-
0035173618
-
A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemora-diotherapy
-
Dunne B, Reynolds JV, Mulligan E, et al. A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemora-diotherapy. J Clin Pathol 2001;54:841-845.
-
(2001)
J Clin Pathol
, vol.54
, pp. 841-845
-
-
Dunne, B.1
Reynolds, J.V.2
Mulligan, E.3
-
17
-
-
33646379877
-
The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas
-
Brucher BL, Becker K, Lordick F, et al. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 2006;106: 2119-2127.
-
(2006)
Cancer
, vol.106
, pp. 2119-2127
-
-
Brucher, B.L.1
Becker, K.2
Lordick, F.3
-
18
-
-
38149082245
-
Histopathological response after preoperative radio-chemotherapy in rectal carcinoma is associated with improved overall survival
-
Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after preoperative radio-chemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008;97:8-13.
-
(2008)
J Surg Oncol
, vol.97
, pp. 8-13
-
-
Rosenberg, R.1
Nekarda, H.2
Zimmermann, F.3
-
19
-
-
20144362218
-
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemor-adiation
-
Chirieac LR, Swisher SG, Ajani JA, et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemor-adiation. Cancer 2005;103:1347-1355.
-
(2005)
Cancer
, vol.103
, pp. 1347-1355
-
-
Chirieac, L.R.1
Swisher, S.G.2
Ajani, J.A.3
-
20
-
-
20944447405
-
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)
-
discussion 817-820
-
Swisher SG, Hofstetter W, Wu TT, et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 2005; 241:810-817; discussion 817-820.
-
(2005)
Ann Surg
, vol.241
, pp. 810-817
-
-
Swisher, S.G.1
Hofstetter, W.2
Wu, T.T.3
-
21
-
-
33845953627
-
Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: A reliable predictor for patient outcome
-
Wu TT, Chirieac LR, Abraham SC, et al. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 2007;31:58-64.
-
(2007)
Am J Surg Pathol
, vol.31
, pp. 58-64
-
-
Wu, T.T.1
Chirieac, L.R.2
Abraham, S.C.3
-
22
-
-
0028305674
-
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma Clinico-pathologic correlations
-
Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinico-pathologic correlations. Cancer 1994;73:2680-2686.
-
(1994)
Cancer
, vol.73
, pp. 2680-2686
-
-
Mandard, A.M.1
Dalibard, F.2
Mandard, J.C.3
-
23
-
-
33947534209
-
American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multi-modality therapy for esophageal adenocarcinoma
-
Rizk NP, Venkatraman E, Bains MS, et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multi-modality therapy for esophageal adenocarcinoma. J Clin Oncol 2007;25:507-512.
-
(2007)
J Clin Oncol
, vol.25
, pp. 507-512
-
-
Rizk, N.P.1
Venkatraman, E.2
Bains, M.S.3
-
24
-
-
27644561794
-
Histomor-phologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radioche-motherapy for esophageal cancer: Implications for response classification
-
Schneider PM, Baldus SE, Metzger R, et al. Histomor-phologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radioche-motherapy for esophageal cancer: implications for response classification. Ann Surg 2005;242:684-692.
-
(2005)
Ann Surg
, vol.242
, pp. 684-692
-
-
Schneider, P.M.1
Baldus, S.E.2
Metzger, R.3
-
25
-
-
22344446070
-
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
-
Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005;23:4330-4337.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4330-4337
-
-
Berger, A.C.1
Farma, J.2
Scott, W.J.3
-
26
-
-
0035886548
-
Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma
-
Brucher BL, Stein HJ, Werner M, et al. Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma. Cancer 2001;92: 2228-2233.
-
(2001)
Cancer
, vol.92
, pp. 2228-2233
-
-
Brucher, B.L.1
Stein, H.J.2
Werner, M.3
-
27
-
-
14144254112
-
Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophago-gastric junction
-
von Rahden BH, Stein HJ, Feith M, et al. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophago-gastric junction. J Clin Oncol 2005;23:874-879.
-
(2005)
J Clin Oncol
, vol.23
, pp. 874-879
-
-
Von Rahden, B.H.1
Stein, H.J.2
Feith, M.3
|